Skip to main content
Unichem Laboratories Ltd. logo

Unichem Laboratories Ltd. — Investor Relations & Filings

Ticker · UNICHEMLAB ISIN · INE351A01035 LEI · 3358008AHXLO9H4C2Q20 BSE.NS Manufacturing
Open in API
Filings indexed 1,119 across all filing types
Latest filing 2022-05-17 Regulatory Filings
Country IN India
Listing BSE.NS UNICHEMLAB

About Unichem Laboratories Ltd.

https://www.unichemlabs.com/

Unichem Laboratories Ltd. focuses on the research, development, manufacturing, and marketing of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs). The company provides solutions across various therapeutic areas, including cardiology, gastroenterology, anti-infectives, diabetology, orthopedics, and neurology. It maintains a significant international footprint, exporting products to regulated markets such as the United States and Europe. The manufacturing infrastructure is built to comply with global standards, featuring approvals from international regulatory agencies. Through its dedicated research and development initiatives, the organization develops a robust pipeline of generic products and complex formulations aimed at improving patient outcomes globally.

Recent filings

Filing Released Lang Actions
Submission of Advertisement Published in Newspapers regarding Notice for transfer of Equity Shares and Unclaimed Dividend to the Investor Education and Protection Fund (IEPF) Account.
Regulatory Filings Classification · 95% confidence The document is a letter from Unichem Laboratories Limited to stock exchanges regarding the submission of newspaper advertisements about the transfer of equity shares and unclaimed dividends to the Investor Education and Protection Fund (IEPF) account. It includes a notice published in newspapers and details about the transfer process under regulatory rules. The content is an announcement informing the exchanges and shareholders about the notice publication and the upcoming transfer of shares to IEPF. There are no financial statements, management discussion, or detailed financial data present. The document is primarily an announcement of a regulatory compliance action and publication of a notice, not a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance communication.
2022-05-17 English
Newspaper Advertisements
Regulatory Filings Classification · 95% confidence The document is a letter from the company to stock exchanges submitting copies of newspaper advertisements regarding the transfer of equity shares and unclaimed dividends to the Investor Education and Protection Fund (IEPF) account. It includes a notice published in newspapers and details about the transfer process under regulatory rules. The document does not contain financial statements, management discussion, or detailed financial data. It is primarily an announcement and submission of a public notice related to regulatory compliance and shareholder information. The document length is 8204 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance document rather than a financial report or dividend notice.
2022-05-17 English
Disclosure of other UPSI/material event
Capital/Financing Update Classification · 95% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding a strategic investment transaction. It details the sale of the company's entire shareholding in Optimus Drugs Private Limited to another entity, including the percentage of shares sold, consideration amount, and regulatory approvals required. The document references compliance with SEBI Listing Regulations and provides detailed disclosures about the transaction. There is no financial statement or report content, but rather an announcement of a capital transaction involving share transfer. This fits the definition of a Capital/Financing Update (CAP) as it updates on company fundraising or capital structure changes through share sale.
2022-05-10 English
Liquidation of Strategic Investment made by the Company .
Capital/Financing Update Classification · 95% confidence The document is an official communication addressed to stock exchanges regarding a strategic investment sale by the company. It references Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, which pertains to disclosures of material events or information by listed entities. The content details the sale of shares in a subsidiary company, including transaction terms, shareholding percentages, and regulatory approvals. There are no financial statements or detailed financial performance data presented, nor is this a report or earnings release. Instead, it is an update on a capital transaction and shareholding change. This fits the definition of a Capital/Financing Update (CAP) filing, which covers company fundraising, financing activities, or capital structure changes. The document length is sufficient and contains substantive information about the transaction, not merely an announcement of a report or certification. Therefore, the appropriate classification is CAP.
2022-05-10 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges referencing a SEBI circular about fundraising by issuance of debt securities by large entities. The letter confirms that the company is not a 'Large Corporate' as defined in the circular and provides an unaudited outstanding term amount as of March 31, 2022. The document is short (1219 characters) and serves as a compliance confirmation or regulatory disclosure rather than a full financial report or detailed update. It does not contain financial statements or detailed financial analysis. It is an official regulatory communication related to compliance with SEBI rules, fitting best under Regulatory Filings (RNS).
2022-04-28 English
COMPLIANCE CERTIFICATE UNDER REGULATION 40(9) OF THE SEBI (LODR) REGULATIONS, 2015 FOR THE YEAR ENDED 31.03.2022
Regulatory Filings Classification · 95% confidence The document is a certificate under regulation 40(9) & 40(10) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the financial year ended March 31, 2022. It is signed by a company secretary and confirms compliance with share transfer regulations. The document is a compliance certificate, not a financial report or announcement of financial results. It does not contain financial statements or management discussion but is a regulatory compliance certificate related to share transfer processes. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for compliance certificates and regulatory announcements that do not fit other specific categories.
2022-04-14 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.